Sigyn Therapeutics SIGY Estimates

OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT
Analyst Estimates

Sigyn Therapeutics, Inc. Annual Revenue Estimates

Periods 4
Next Period 2017
Consensus 2.01 M

Analysts expect Sigyn Therapeutics, Inc. to report revenue of 2.01 M for 2017, against a range of 1.85 M to 2.18 M.

Metric 2017201820192020
Reported (Actual) --
High Estimate 2.18 M7.10 M
Low Estimate 1.85 M6.39 M
Consensus Estimate 2.01 M6.74 M
Analyst Estimates

Sigyn Therapeutics, Inc. Annual Earnings Per Share (EPS) Estimates

Periods 6
Next Period 2017
Consensus -444.31

Analysts expect Sigyn Therapeutics, Inc. to report earnings per share of -444.31 for 2017, against a range of -459.90 to -428.72.

Metric 201720182019202020212022
Reported (Actual) --
High Estimate -428.72-260.75
Low Estimate -459.90-298.03
Consensus Estimate -444.31-279.39

Sigyn Therapeutics, Inc. Estimates API

Pull Wall Street consensus for Sigyn Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=SIGY&mode=revenue&api_key=YOUR_API_KEY